Effects of Omega-3 Fatty Acid Supplementation on Vascular Access Thrombosis in Polytetrafluorethylene Grafts
Objective
The purpose of this study was to investigate the effects of orally administered over-the-counter omega-3 (n-3) fatty acid supplements on primary patency of polytetrafluoroethylene (PTFE) grafts.
Design
This study was conducted with a triple-blind, permuted-block, randomized, placebo-controlled experimental design.
Setting
Dialysis clinics with patients who, in accordance with physician diagnosis, needed a new PTFE graft.
Patients and Other Participants
Patients on long-term hemodialysis with newly placed PTFE grafts who were unable to receive a native arteriovenous fistula.
Intervention
Patients were followed prospectively for 8 months after they had been placed into an n-3 fatty acid or control group and were monitored for primary patency.
Main Outcome Variable
Primary patency of the PTFE graft.
Results
The n-3 fatty acid group had a mean PTFE graft primary patency rate of 254.2 days (SEM = 51.8), and the control group had a mean PTFE graft primary patency rate of 254.1 days (SEM = 34.6), revealing no significant difference in survival time between groups.
Conclusions
No significant differences in primary patency rates were noted in the experimental and control groups.
To access this article, please choose from the options below
Data were collected in clinics associated with Central Texas Nephrology Associates.
PII: S1051-2276(06)00163-4
doi:10.1053/j.jrn.2006.07.009
© 2007 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.

